ALGN250117C560000
- 0.05
- 0.000.00%
Align Technology Newsroom
Mizuho Securities Maintains Align Technology(ALGN.US) With Buy Rating, Announces Target Price $295
HSBC Adjusts Align Technology Price Target to $300 From $320, Maintains Buy Rating
The Analyst Verdict: Align Tech In The Eyes Of 3 Experts
Align Technology Is Maintained at Buy by Jefferies
Jefferies Initiates Align Technology(ALGN.US) With Buy Rating, Announces Target Price $260
Express News | Align Technology Inc : Jefferies Cuts Target Price to $260 From $285
Piper Sandler Maintains Align Technology(ALGN.US) With Buy Rating, Maintains Target Price $275
Align Technology (NASDAQ:ALGN) Could Be Struggling To Allocate Capital
Align Technology Shares Hurt by Macro Issues, Decline in ASPs
Align Technology Announces NFL Quarterback Patrick Mahomes Joins the Invisalign Brand Smile Squad
Why Align Technology (ALGN) Is Among the Best 3D Printing and Additive Manufacturing Stocks to Buy?
Zacks Investment Ideas Feature Highlights: Align Technology and Coca-Cola
Stifel Maintains Align Technology(ALGN.US) With Buy Rating, Maintains Target Price $275
Positive Outlook for Align Technology: Strategic Restructuring and Earnings Growth Drive Buy Recommendation
2 Strong Stocks to Buy Now While They're Still on Sale
Evercore Maintains Align Technology(ALGN.US) With Buy Rating, Cuts Target Price to $240
Align Technology Boosted By Improving Sentiment, Easing Comps, Margins, Earns Analyst Upgrade
Leerink Partners Upgrades Align Technology(ALGN.US) to Buy Rating, Raises Target Price to $280
Leerink Partners Upgrades Align Technology to Outperform From Market Perform, Adjusts Price Target to $280 From $235
Fluctuations are expected to continue in the early days of Trump's presidency, with Citigroup favoring Medical, Financial, and other defensive Industries.
In the market volatility and uncertainty following Trump's inauguration, defensive industries such as Medical Care and finance are favored in the model portfolio created by Citigroup strategists.